Thursday, March 3, 2011

Painkiller Use Related to Erection Problems

Impotence more common in men who pop painkillers: "NEW YORK (Reuters Health) - Aging men tend to take more painkillers and experience more sexual problems, but does that mean one causes the other?

Researchers found that regular users of drugs like aspirin, acetaminophen, ibuprofen, and Celebrex were 38 percent more likely to have erectile dysfunction than men who didn't take the so-called nonsteroidal anti-inflammatory painkillers.

Such drugs are thought to block the hormones that govern men's erections.

After accounting for factors like age, weight, high blood pressure and heart disease, the researchers still found a 38-percent higher risk of erectile dysfunction among men on painkillers.

Still, because the study didn't test painkillers directly, Inman cautioned that men shouldn't stop using painkillers for fear that it would cut their chances of getting an erection.




"

Friday, February 25, 2011

PSA spikes are poor predictors of prostate cancer

PSA spikes are poor predictors of prostate cancer: "CHICAGO (Reuters) - A sudden spike in blood levels of prostate specific antigen, or PSA, is not an accurate way to predict prostate cancer, and testing for such changes can lead to overtreatment, U.S. researchers said on Thursday.

If a man's PSA has risen rapidly in recent years, there is no cause for concern if his total PSA level is still low and his clinical exam is normal.

He said the large study adds to others showing that changes in PSA should not be used alone as a basis for getting a biopsy. Besides cancer, other conditions, including an enlarged prostate and infections, can cause PSA levels to rise.

Once diagnosed, more than 90 percent of men with low-grade prostate cancer get treated, most often with surgery or radiation. Both can cause lasting side effects including impotence or incontinence.




"

Wednesday, February 16, 2011

Drug may slow growth of early prostate cancer (AP)

Drug may slow growth of early prostate cancer
(AP)
: "AP - A new study suggests a way to help men with early, low-risk prostate cancer avoid being overtreated for a disease that in most cases will never threaten their lives. It found that a drug can slow the growth of these tumors in men who opt to be monitored instead of having treatment right away."

This is the first time that a drug for treating enlarged prostates also has been shown to help treat prostate cancer in a rigorous study. It may persuade more men to choose active surveillance, or "watchful waiting," instead of rushing to have treatments that can leave them with urinary or sexual problems, doctors say.

However, the results also show that most of these men do very well with no treatment at all.


Doctors know that drugs that shrink the prostate — GlaxoSmithKline PLC's Avodart and Merck & Co.'s Proscar — can help prevent prostate cancer. But federal health advisers recently recommended against taking them for this purpose because of potential risks.

The new study tested Avodart "not to prevent cancer, but to prevent the progression" of it in men who already have the disease, which may be a much better use of such drugs, said the study's leader, Dr. Neil Fleshner

Doctors don't think Avodart can cure cancers, but it seems to suppress it, said Dr. Howard Sandler, a prostate cancer specialist at Cedars-Sinai Medical Center in Los Angeles. He had no role in the study but is involved with the cancer conference.

Sandler said Avodart might relieve some men's anxiety about monitoring their disease and may make them more comfortable not having immediate treatment.

Early balding related to prostate cancer risk

Early balding linked to risk of prostate cancer: "LONDON (Reuters) - A study showing that men who start to go bald at 20 may be more likely to develop prostate cancer in later life suggests they might benefit from early screening or preventative therapy, scientists said on Tuesday.

If the men only started going bald when they were 30 or 40, there was no difference in their risk of developing prostate cancer compared to the healthy group.

At present there is no hard evidence to show any benefit from screening the general population for prostate cancer. We need a way of identifying those men who are at high risk.

Further work should be done, both at the molecular level and with larger groups of men, to find the missing link between androgens, early balding and prostate cancer.


"

Thursday, February 10, 2011

Diagnosis of Testicular cancer after 40 doubles risk of death

Testicular cancer deaths double with after 40 diagnosis: "NEW YORK (Reuters) - Men diagnosed with testicular cancer at 40 years of age or older have twice the risk of dying from the disease as younger patients, according to a study of nearly 28,000 men.

Mortality was doubled in patients diagnosed over the age of 40, the study found. But, those diagnosed after 1987 were less likely to die during follow-up than men diagnosed earlier, possibly due to the introduction of a certain kind of chemotherapy about 10 years earlier.

Several factors may account for the age-related mortality difference, including the fact that many older patients are often not treated with the same intensity as younger patients, the researchers said.

"In a cancer that is so highly curable, any influence that confers an increased risk of disease-specific mortality must be identified, and interventional strategies adopted," they said.


"

Thursday, February 3, 2011

New test being developed to help spot lethal prostate cancer

Gene test may help spot lethal prostate tumors: "CHICAGO (Reuters) - Prostate tumors with a distinctive four-gene 'signature' are far more lethal than others, laying the groundwork for a test to predict which tumors need aggressive treatment, U.S. researchers said on Wednesday.

"This would have 92 percent accuracy relative to what we currently have, which is at best 75 percent accuracy," said Dr. Ronald DePinho of Dana-Farber's Belfer Institute for Applied Cancer Science in Massachusetts.

DePinho said the results will make a big impact on how men are tested and treated for prostate cancer, the second most common cancer in men worldwide after lung cancer, killing 254,000 a year.

"The goal is to do this within about a year or maybe a bit longer than that," said DePinho, who has a stake in the company.



"

Saturday, January 29, 2011

No bone prevention from extra Vit D and calcium

xtra calcium, vitamin D no bone booster for men: "NEW YORK (Reuters Health) - Taking extra vitamin D and calcium doesn't seem to prevent bone-thinning in older men, according to Australian researchers.

Despite the findings, people still need to get enough calcium and vitamin D to reduce the risk of osteoporosis, or bone thinning.

The recommended daily intake of vitamin D is 600 IU in adults up to age 70, and 800 IU for older people, according to the National Institutes of Health (NIH). A 6-month supply of vitamin D supplements can be bought for less than $10, and many multivitamins contain the recommended daily dose of vitamin D.
As for calcium, the NIH advises 1,000 mg per day for men ages19-70, and then 1,200 mg per day for men older than 70.
To build bone density, weight-bearing exercise is needed, such as running or weight-lifting, according to the NIH.


"